AIRS
AirSculpt Technologies, Inc.2.5700
-0.0600-2.28%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
160.46MP/E (TTM)
-Basic EPS (TTM)
-0.30Dividend Yield
0%Recent Filings
8-K
8-K
8-K
CAO resigns effective August 1
AirSculpt Technologies announced the resignation of Chief Accounting Officer Philip Bodie, effective August 1, 2025, following his tender on July 29. No successor or interim arrangements disclosed. This leadership shift arrives amid the company's emerging growth status, potentially straining financial oversight during expansion.
8-K
Q2 revenue dips, CFO retiring
AirSculpt Technologies reported Q2 2025 results with revenue down 13.7% to $44.0 million and case volume off 14.1% from last year, yet net loss narrowed to $0.6 million from $3.2 million. The company piloted skin tightening for GLP-1 users and expanded financing, while trimming debt by $16 million post-stock offering. CFO Dennis Dean plans retirement but stays until a successor arrives. Guidance holds at $160-170 million revenue and $16-18 million Adjusted EBITDA. Leadership transition looms.
10-Q
Q2 FY2025 results
AirSculpt's Q2 revenue fell 13.7% y/y to $44.0M amid softer aesthetics demand, yet swung to a slim $0.8M operating profit from a $5.0M loss, thanks to sharp SG&A cuts including 33.9% lower ad spend and no repeat of last year's severance hits. Gross margin edged up to 60.9% from 63.1%, while diluted EPS improved to -$0.01 from -$0.06, aligning with 59.6M weighted shares. Cash held steady at $8.2M with full $5.0M revolver access, bolstered by a June equity raise netting $13.8M to trim term debt to $57.7M at 7.83% (maturing May 2027). Free cash flow stood at $3.7M (derived) for H1. Non-GAAP Adjusted EBITDA dipped to $5.8M from $6.9M but held a solid 13.3% margin. Debt covenants eased via March amendment, with sponsor's $10M backstop met by timely prepay. Still, rising weight-loss drug competition shadows case volumes.
IPO
Website
Employees
Sector
Industry
ALUR
Allurion Technologies, Inc.
1.54+0.02
AMS
American Shared Hospital Servic
2.13-0.01
ARDT
Ardent Health, Inc.
8.93+0.03
BDMD
Baird Medical Investment Holdin
1.37+0.02
FCHS
First Choice Healthcare Solutio
0.01+0.00
HCA
HCA Healthcare, Inc.
469.79-7.19
INMD
InMode Ltd.
14.48+0.15
PAIYY
Aesthetic Medical International
0.13+0.00
SGRY
Surgery Partners, Inc.
15.52+0.08
VERO
Venus Concept Inc.
2.26+0.59